Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

75.57
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
63.76
Today|||52-Week Range
86.27
+5.53%
Year-to-Date
GILD Regular Dividend: GILD began trading ex-dividend on 12/14/17. A $0.52 dividend will be paid to shareholders of record as of 12/15/17.
CAR T Stocks in Focus with ASH 2017 Meet: GILD, JUNO & More
Dec 15 / Zacks.com - Paid Partner Content
Jim Simons: Pioneer Quant Manager
Dec 12 / GuruFocus News - Paid Partner Content
Cancer Space Update: Roche, Pfizer & Regeneron Make Data Presentations
Dec 15 / Zacks.com - Paid Partner Content
4 Signs the Bull Market in Stocks Remains Incredibly Strong
Dec 12 / TheStreet.com - Paid Partner Content
6 Stocks Boosting Earnings and Revenue
Dec 14 / GuruFocus News - Paid Partner Content
Bluebird's Shares Jump on Strong Data for CAR-T Therapy
Dec 12 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: ASH Data in Focus, Gilead to Buy Cell Design Labs
Dec 13 / Zacks.com - Paid Partner Content
Gilead (GILD) Posts Updated Data on CAR-T Therapy Yescarta
Dec 11 / Zacks.com - Paid Partner Content
Juno Reports Additional Data on CAR-T Therapy, Shares Drop
Dec 12 / Zacks.com - Paid Partner Content
Novartis Reports Updated Results from Kymriah's JULIET Study
Dec 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close75.57
Today’s open75.00
Day’s range74.10 - 75.73
Volume15,367,239
Average volume (3 months)9,037,449
Market cap$98.7B
Data as of 4:15pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-16.54%
Earnings growth (this year)-24.74%
Earnings growth (next 5 years)-6.55%
Revenue growth (last year)-5.37%
P/E ratio8.6
Price/Sales3.21
Price/Book5.24

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen0.000.00%
BIIBBiogen0.000.00%
ILMNIllumina Inc0.000.00%
----
Data as of 4:15pm ET, 12/15/2017

Financials

Next reporting dateFebruary 6, 2018
EPS forecast (this quarter)$1.68
Annual revenue (last year)$30.3B
Annual profit (last year)$13.5B
Net profit margin44.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts